{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T20:27:36Z","timestamp":1769027256749,"version":"3.49.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["190793"],"award-info":[{"award-number":["190793"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","japha.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Pharmacists Association"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.japh.2025.102973","type":"journal-article","created":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T00:14:35Z","timestamp":1762215275000},"page":"102973","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Implementation of community pharmacy\u2013based testing and treatment for Chlamydia trachomatis and Neisseria gonorrhoeae in Nova Scotia (Swab-Rx study)"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-7101-8994","authenticated-orcid":false,"given":"Mackenzie","family":"d\u2019Entremont-Harris","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9435-9377","authenticated-orcid":false,"given":"Tasha D.","family":"Ramsey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shea J.L.","family":"McInnis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Connor","family":"Booker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-1214-7835","authenticated-orcid":false,"given":"Dylan","family":"DeYoung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Bishop","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9292-8911","authenticated-orcid":false,"given":"Kirk","family":"Furlotte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5377-2528","authenticated-orcid":false,"given":"Todd F.","family":"Hatchette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyle John","family":"Wilby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.japh.2025.102973_bib1","series-title":"Global progress report on HIV, viral hepatitis and sexually transmitted infections, 2021. Accountability for the global health sector strategies 2016-2021: actions for impact","year":"2021"},{"issue":"4","key":"10.1016\/j.japh.2025.102973_bib5","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/S0091-7435(02)00058-0","article-title":"Asymptomatic sexually transmitted diseases: the case for screening","volume":"36","author":"Farley","year":"2003","journal-title":"Prev Med"},{"issue":"9","key":"10.1016\/j.japh.2025.102973_bib6","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/00007435-200209000-00001","article-title":"Azithromycin versus doxycycline for genital chlamydial infections: a meta-analysis of randomized clinical trials","volume":"29","author":"Lau","year":"2002","journal-title":"Sex Transm Dis"},{"issue":"9","key":"10.1016\/j.japh.2025.102973_bib7","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1093\/cid\/ciz429","article-title":"Chlamydia trachomatis and the risk of pelvic inflammatory disease, ectopic pregnancy, and female infertility: a retrospective cohort study among primary care patients","volume":"69","author":"den Heijer","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.japh.2025.102973_bib8","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/OLQ.0000000000000980","article-title":"Proportion of incident human immunodeficiency virus cases among men who have sex with men attributable to gonorrhea and chlamydia: a modeling analysis","volume":"46","author":"Jones","year":"2019","journal-title":"Sex Transm Dis"},{"issue":"4","key":"10.1016\/j.japh.2025.102973_bib9","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1097\/QAI.0b013e3181c3ef29","article-title":"Rectal gonorrhea and chlamydia reinfection is associated with increased risk of HIV seroconversion","volume":"53","author":"Bernstein","year":"2010","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"13","key":"10.1016\/j.japh.2025.102973_bib10","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000003077","article-title":"Chlamydia Trachomatis infection-associated risk of cervical cancer: a meta-analysis","volume":"95","author":"Zhu","year":"2016","journal-title":"Medicine (Baltimore)"},{"issue":"8","key":"10.1016\/j.japh.2025.102973_bib11","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1002\/ijc.32999","article-title":"Serologic markers of chlamydia trachomatis and other sexually transmitted infections and subsequent ovarian cancer risk: results from the EPIC cohort","volume":"147","author":"Idahl","year":"2020","journal-title":"Int J Cancer"},{"issue":"2","key":"10.1016\/j.japh.2025.102973_bib12","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/jnci\/djy084","article-title":"Antibodies against chlamydia trachomatis and ovarian cancer risk in two independent populations","volume":"111","author":"Trabert","year":"2019","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"10.1016\/j.japh.2025.102973_bib13","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1007\/s10096-016-2866-7","article-title":"Gonorrhea infection increases the risk of prostate cancer in Asian population: a nationwide population-based cohort study","volume":"36","author":"Wang","year":"2017","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.japh.2025.102973_bib14","series-title":"A Pan-Canadian Framework for Action: Reducing the Health Impact Of Sexually Transmitted And Blood-Borne Infections in Canada by 2030","year":"2018"},{"issue":"8","key":"10.1016\/j.japh.2025.102973_bib16","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2013-003338","article-title":"To develop and measure the effectiveness and acceptability of a pharmacy-based chlamydia screening intervention in Australia","volume":"3","author":"Gudka","year":"2013","journal-title":"BMJ Open"},{"issue":"1","key":"10.1016\/j.japh.2025.102973_bib17","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1071\/PY12135","article-title":"\u2018Catching Chlamydia\u2019: combining cash incentives and community pharmacy access for increased chlamydia screening, the view of young people","volume":"21","author":"Parker","year":"2015","journal-title":"Aust J Prim Health"},{"issue":"9","key":"10.1016\/j.japh.2025.102973_bib18","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-052228","article-title":"Young people's perceptions of accessing a community pharmacy for a chlamydia testing kit: a qualitative study based in North East England","volume":"11","author":"Ahmaro","year":"2021","journal-title":"BMJ Open"},{"issue":"6","key":"10.1016\/j.japh.2025.102973_bib19","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1093\/ijpp\/riac057","article-title":"Investigating community pharmacists' perceptions of delivering chlamydia screening to young people: a qualitative study using normalisation process theory to understand professional practice","volume":"30","author":"Ahmaro","year":"2022","journal-title":"Int J Pharm Pract"},{"issue":"4","key":"10.1016\/j.japh.2025.102973_bib20","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1136\/qshc.2006.020883","article-title":"Chlamydia testing in community pharmacies: evaluation of a feasibility pilot in south east London","volume":"16","author":"Baraitser","year":"2007","journal-title":"Qual Saf Health Care"},{"key":"10.1016\/j.japh.2025.102973_bib21","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1472-6874-9-7","article-title":"Delivery of chlamydia screening to young women requesting emergency hormonal contraception at pharmacies in Manchester, UK: a prospective study","volume":"9","author":"Brabin","year":"2009","journal-title":"BMC Womens Health"},{"issue":"1","key":"10.1016\/j.japh.2025.102973_bib22","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1136\/jfprhc.2010.0003","article-title":"Chlamydia screening by community pharmacists: a qualitative study","volume":"37","author":"Dabrera","year":"2011","journal-title":"J Fam Plann Reprod Health Care"},{"issue":"8","key":"10.1016\/j.japh.2025.102973_bib23","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1136\/sextrans-2014-051994","article-title":"Developing and testing accelerated partner therapy for partner notification for people with genital Chlamydia trachomatis diagnosed in primary care: a pilot randomised controlled trial","volume":"91","author":"Estcourt","year":"2015","journal-title":"Sex Transm Infect"},{"issue":"4","key":"10.1016\/j.japh.2025.102973_bib24","first-page":"206","article-title":"Staff and users' experiences of pharmacy-based sexual and reproductive health services: a qualitative interview study from the UK","volume":"8","author":"Gauly","year":"2020","journal-title":"Pharm J Pharm Educ Pract"},{"issue":"1","key":"10.1016\/j.japh.2025.102973_bib25","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1471-0528.2009.02362.x","article-title":"A qualitative study of pharmacists' views on offering chlamydia screening to women requesting emergency hormonal contraception: pharmacy chlamydia screening after emergency contraception","volume":"117","author":"Thomas","year":"2010","journal-title":"BJOG"},{"issue":"12","key":"10.1016\/j.japh.2025.102973_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0315191","article-title":"Community pharmacies: key players in point-of-care diagnostics for STI screening in Africa","volume":"19","author":"Kiragga","year":"2024","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.japh.2025.102973_bib27","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1097\/00007435-200205000-00008","article-title":"Community-based chlamydia and gonorrhea screening through the United States mail, San Francisco","volume":"29","author":"Bloomfield","year":"2002","journal-title":"Sex Transm Dis"},{"issue":"6","key":"10.1016\/j.japh.2025.102973_bib28","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1071\/SH15031","article-title":"Exploring pharmacy and home-based sexually transmissible infection testing","volume":"12","author":"Habel","year":"2015","journal-title":"Sex Health"},{"issue":"1","key":"10.1016\/j.japh.2025.102973_bib29","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/s11096-010-9460-3","article-title":"A pharmacy-based private chlamydia screening programme: results from the first 2 years of screening and treatment","volume":"33","author":"Anderson","year":"2011","journal-title":"Int J Clin Pharm"},{"issue":"2","key":"10.1016\/j.japh.2025.102973_bib30","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1136\/sti.2006.022657","article-title":"Sexually transmitted and reproductive tract infections in symptomatic clients of pharmacies in Lima, Peru","volume":"83","author":"Garc\u00eda","year":"2007","journal-title":"Sex Transm Infect"},{"issue":"9","key":"10.1016\/j.japh.2025.102973_bib31","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.2105\/AJPH.89.9.1322","article-title":"Evaluating the public health impact of health promotion interventions: the RE-AIM framework","volume":"89","author":"Glasgow","year":"1999","journal-title":"Am J Public Health"},{"key":"10.1016\/j.japh.2025.102973_bib32","article-title":"Standards for reporting implementation studies (StaRI) statement","volume":"356","author":"Pinnock","year":"2017","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.japh.2025.102973_bib36","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2014A metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"key":"10.1016\/j.japh.2025.102973_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: building an international community of software platform partners","volume":"95","author":"Harris","year":"2019","journal-title":"J Biomed Inform"},{"issue":"1","key":"10.1016\/j.japh.2025.102973_bib39","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12913-017-2031-8","article-title":"Acceptability of healthcare interventions: an overview of reviews and development of a theoretical framework","volume":"17","author":"Sekhon","year":"2017","journal-title":"BMC Health Serv Res"},{"issue":"1","key":"10.1016\/j.japh.2025.102973_bib41","doi-asserted-by":"crossref","first-page":"97","DOI":"10.5152\/FNJN.2020.19032","article-title":"Sexual health\/reproductive health-related problems of lesbian, gay, bisexual and transgender people in Turkey and their health-care needs","volume":"28","author":"Ta\u015fk\u0131n","year":"2020","journal-title":"Florence Nightingale J Nurs"},{"issue":"3","key":"10.1016\/j.japh.2025.102973_bib42","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1053\/j.spid.2005.04.007","article-title":"Bacterial sexually transmitted infections in gay, lesbian, and bisexual adolescents: medical and public health perspectives","volume":"16","author":"Benson","year":"2005","journal-title":"Semin Pediatr Infect Dis"},{"issue":"6","key":"10.1016\/j.japh.2025.102973_bib43","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1093\/oxfordjournals.aje.a113056","article-title":"Comparative prevalence rates of sexually transmitted diseases in heterosexual and homosexual men","volume":"112","author":"Judson","year":"1980","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.japh.2025.102973_bib44","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/5758387","article-title":"Extragenital infections caused by chlamydia trachomatis and neisseria gonorrhoeae: a review of the literature","volume":"2016","author":"Chan","year":"2016","journal-title":"Infect Dis Obstet Gynecol"},{"issue":"9","key":"10.1016\/j.japh.2025.102973_bib45","doi-asserted-by":"crossref","first-page":"285","DOI":"10.14745\/ccdr.v46i09a06","article-title":"Extragenital testing increases case detection of gonorrhea and chlamydia: the impact of implementing nucleic acid amplification testing","volume":"46","author":"Friedman","year":"2020","journal-title":"Can Commun Dis Rep"},{"issue":"2","key":"10.1016\/j.japh.2025.102973_bib46","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/OLQ.0000000000000088","article-title":"Comparing azithromycin and doxycycline for the treatment of rectal chlamydial infection: a retrospective cohort study","volume":"41","author":"Khosropour","year":"2014","journal-title":"Sex Transm Dis"},{"issue":"5","key":"10.1016\/j.japh.2025.102973_bib47","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1093\/cid\/ciab153","article-title":"Doxycycline versus azithromycin for the treatment of rectal chlamydia in men who have sex with men: a randomized controlled trial","volume":"73","author":"Dombrowski","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"25","key":"10.1016\/j.japh.2025.102973_bib48","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1056\/NEJMoa2031631","article-title":"Azithromycin or doxycycline for asymptomatic rectal chlamydia trachomatis","volume":"384","author":"Lau","year":"2021","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.japh.2025.102973_bib49","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/S1473-3099(22)00148-7","article-title":"Doxycycline versus azithromycin for the treatment of anorectal chlamydia trachomatis infection in women concurrent with vaginal infection (CHLAZIDOXY study): a multicentre, open-label, randomised, controlled, superiority trial","volume":"22","author":"Peuchant","year":"2022","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"10.1016\/j.japh.2025.102973_bib50","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1001\/jama.2012.176575","article-title":"Neisseria gonorrhoeae treatment failure and susceptibility to cefixime in Toronto, Canada","volume":"309","author":"Allen","year":"2013","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.japh.2025.102973_bib51","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.japh.2023.10.029","article-title":"Pharmacy-based sexually transmitted infection service implementation considerations: a scoping review","volume":"64","author":"d'Entremont-Harris","year":"2024","journal-title":"J Am Pharm Assoc"},{"issue":"1","key":"10.1016\/j.japh.2025.102973_bib52","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.japh.2022.10.011","article-title":"A scoping review of the minority stress processes experienced by sexual and gender minority individuals in pharmacy settings: implications for health care avoidance","volume":"63","author":"Villemure","year":"2023","journal-title":"J Am Pharm Assoc"},{"issue":"2","key":"10.1016\/j.japh.2025.102973_bib53","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-054121","article-title":"PrEP distribution in pharmacies: a systematic review","volume":"12","author":"Kennedy","year":"2022","journal-title":"BMJ Open"},{"issue":"5","key":"10.1016\/j.japh.2025.102973_bib54","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1007\/s11096-022-01520-6","article-title":"A systematic review and pooled prevalence of burnout in pharmacists","volume":"45","author":"Dee","year":"2023","journal-title":"Int J Clin Pharm"}],"container-title":["Journal of the American Pharmacists Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319125006521?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319125006521?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T04:33:43Z","timestamp":1768970023000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1544319125006521"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":45,"alternative-id":["S1544319125006521"],"URL":"https:\/\/doi.org\/10.1016\/j.japh.2025.102973","relation":{},"ISSN":["1544-3191"],"issn-type":[{"value":"1544-3191","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Implementation of community pharmacy\u2013based testing and treatment for Chlamydia trachomatis and Neisseria gonorrhoeae in Nova Scotia (Swab-Rx study)","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Pharmacists Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.japh.2025.102973","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102973"}}